Association between hepatitis C virus core protein and carotid atherosclerosis

被引:105
作者
Ishizaka, Y
Ishizaka, N
Takahashi, E
Unuma, T
Tooda, EI
Hashimoto, H
Nagai, R
Yamakado, M
机构
[1] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan
[2] Mitsui Mem Hosp, Ctr Multiphas Hlth Testing & Serv, Tokyo, Japan
[3] Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo 173, Japan
关键词
carotid artery; inflammation; plaque; population study;
D O I
10.1253/circj.67.26
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A link between certain infectious microorganisms and an increased risk of atherosclerotic disease has been suggested. By analyzing the data of subjects who had undergone general health-screening tests, a possible association between carotid atherosclerosis and seropositivity of antibody against hepatitis C virus (HCV) has been previously reported. In the present study, a possible link between carotid atherosclerosis and HCV core protein positivity was assessed, because it is postulated to be a better marker of viremia and thus persistent infection. Of the 1992 enrolled subjects, 496 (25%) had carotid artery plaque, and 25 (1.3%) were positive for HCV core protein. Carotid artery plaque was positive in 480/1967 (24%) and 16/25 (64%) of the core protein-negative and core protein-positive subjects, respectively (p<0.0001 by chi(2) test). Serum concentrations of transaminases were higher in core protein-positive subjects, but albumin concentrations were not significantly different between the 2 groups. Multivariate logistic regression analysis showed that HCV core protein positivity is an independent predictor of carotid plaque with an odds ratio of 5.61 (95% confidence interval 2.06-15.26, p<0.001). These data further support the possible link between persistent HCV infection and carotid atherosclerosis in the subjects without severe liver dysfunction.
引用
收藏
页码:26 / 30
页数:5
相关论文
共 18 条
[1]  
ADAM E, 1987, LANCET, V2, P291
[2]   Novel clinical markers of vascular wall inflammation [J].
Blake, GJ ;
Ridker, PM .
CIRCULATION RESEARCH, 2001, 89 (09) :763-771
[3]   Anti-endothelial cell auto-antibodies in hepatitis C virus mixed cryoglobulinemia [J].
Cacoub, P ;
Ghillani, P ;
Revelen, R ;
Thibault, V ;
Calvez, V ;
Charlotte, F ;
Musset, L ;
Youinou, P ;
Piette, JC .
JOURNAL OF HEPATOLOGY, 1999, 31 (04) :598-603
[4]   Serum level of soluble intercellular adhesion molecule 1 in patients with chronic liver disease related to hepatitis C virus: A prognostic marker for responses to interferon treatment [J].
Capra, F ;
De Maria, E ;
Lunardi, C ;
Marchiori, L ;
Mezzelani, P ;
Beri, R ;
Gabrielli, GB .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (02) :425-431
[5]   Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening [J].
Ishizaka, N ;
Ishizaka, Y ;
Takahashi, E ;
Tooda, E ;
Hashimoto, H ;
Nagai, R ;
Yamakado, M .
LANCET, 2002, 359 (9301) :133-135
[6]   High serum bilirubin level is inversely associated with the presence of carotid plaque [J].
Ishizaka, N ;
Ishizaka, Y ;
Takahashi, E ;
Yamakado, M ;
Hashimoto, H .
STROKE, 2001, 32 (02) :581-583
[7]   Determination of serum hepatitis C virus (HCV) core protein using a novel approach for quantitative evaluation of HCV viraemia in anti-HCV-positive patients [J].
Komatsu, F ;
Takasaki, K .
LIVER, 1999, 19 (05) :375-380
[8]   Cellular response to conditional expression of hepatitis C virus core protein in Huh7 cultured human hepatoma cells [J].
Li, K ;
Prow, T ;
Lemon, SM ;
Beard, MR .
HEPATOLOGY, 2002, 35 (05) :1237-1246
[9]  
MENDALL MA, 1994, BRIT HEART J, V71, P437
[10]  
Moriya K, 2001, CANCER RES, V61, P4365